From ‘junk’ to medicine: the therapeutic potential of dark transcriptome-derived long noncoding RNA

“Being creative about what we can deliver with LNPs is critical...”

Jokūbas Leikauskas, Editor, Nucleic Acid Insights, speaks with Omar F Khan, Assistant Professor in BME and Immunology, Canada Research Chair in Nucleic Acid Therapeutics, University of Toronto, about the emerging field of dark transcriptome medicines, the therapeutic potential of long noncoding RNA, and the critical role of lipid nanoparticle delivery systems in realizing their clinical promise.

Please enter your email to access content Read now